U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H16FN5O2
Molecular Weight 377.3717
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Labuxtinib

SMILES

CC1=CC=C(C=C1NC(=O)C2=CN=C3C=CC=CN23)C4=NOC(=N4)[C@H]5C[C@@H]5F

InChI

InChIKey=RHNJOZCVGSBEAG-KBPBESRZSA-N
InChI=1S/C20H16FN5O2/c1-11-5-6-12(18-24-20(28-25-18)13-9-14(13)21)8-15(11)23-19(27)16-10-22-17-4-2-3-7-26(16)17/h2-8,10,13-14H,9H2,1H3,(H,23,27)/t13-,14-/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
Labuxtinib
INN  
Official Name English
Imidazo[1,2-a]pyridine-3-carboxamide, N-[5-[5-[(1R,2S)-2-fluorocyclopropyl]-1,2,4-oxadiazol-3-yl]-2-methylphenyl]-
Systematic Name English
N-[5-[5-[(1R,2S)-2-Fluorocyclopropyl]-1,2,4-oxadiazol-3-yl]-2-methylphenyl]imidazo[1,2-a]pyridine-3-carboxamide
Systematic Name English
labuxtinib [INN]
Common Name English
Code System Code Type Description
CAS
1426449-01-5
Created by admin on Sat Dec 16 20:18:29 GMT 2023 , Edited by admin on Sat Dec 16 20:18:29 GMT 2023
PRIMARY
PUBCHEM
71280305
Created by admin on Sat Dec 16 20:18:29 GMT 2023 , Edited by admin on Sat Dec 16 20:18:29 GMT 2023
PRIMARY
FDA UNII
QNX4G754W6
Created by admin on Sat Dec 16 20:18:29 GMT 2023 , Edited by admin on Sat Dec 16 20:18:29 GMT 2023
PRIMARY
INN
12711
Created by admin on Sat Dec 16 20:18:29 GMT 2023 , Edited by admin on Sat Dec 16 20:18:29 GMT 2023
PRIMARY